The 52nd edition of the leading clinical reference on treatment of infectious diseases and anti-infective drug information, spiral-bound and printed in a larger font (approximately 8pt) for ease of use. Helpful in day-to-day practice and as a component of your organization's antimicrobial stewardship program, The Sanford Guide provides valuable guidance in the age of antibiotic resistance. Popular with physicians, pharmacists, physician assistants, nurse practitioners, and other clinicians. Coverage includes: Clinical syndromes (pathogens, bacterial, fungal, mycobacterial, parasitic viral), Anti-infective agents (dosing, pediatric adjustments, renal adjustments, adverse effects, activity, pharmacology, drug-drug interactions), Preventative therapy. What's new in 2022: Numerous changes throughout, with major changes in the following areas: New Drugs - Addition of new COVID-19 drugs, cefiderocol, ibrexafungerp, brincidofovir, cabotegravir, doravirine, and more. New Tables - ECMO Drug Dos 2025-04-176932.87 MB324页
2025-05-136921.39 MB96页1
2024-07-316826.01 MB304页
2024-07-316612.18 MB409页
2024-07-316651.24 MB1996页4
2024-08-01667.92 MB376页
2024-08-226636.8 MB426页1
2025-05-1066186.12 MB689页6
2025-04-166668.16 MB447页
2024-07-316512.82 MB88页7
2024-07-3165425.24 MB1052页
2025-05-106591.13 MB376页1
2024-07-266438.89 MB638页
2024-07-3064113.33 MB847页2
2024-07-3164132.8 MB423页
2024-07-316459.97 MB2078页
2024-09-1264141.19 MB379页
2024-07-316269.71 MB223页
2024-12-03624.95 MB149页
2025-03-156293.9 MB384页1
